BGNE, Target 69Flagpole breakout to a lower side. possibly to going to much earlier lower zone of 69
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.24 USD
−881.71 M USD
2.46 B USD
95.95 M
About BEIGENE, LTD.
Sector
CEO
John V. Oyler
Headquarters
George Town
Website
Founded
2010
FIGI
BBG00B6WF7T5
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where BGNE is featured.
